IMP3 Immunohistochemical Expression Is Related with Progression and Metastases in Xenografted and Cutaneous Melanomas

Selective modulation by PARP-1 of HIF-1α-recruitment to chromatin during hypoxia is required for tumor adaptation to hypoxic conditions

(2021) Juan Manuel Martí et al.   Redox Biology

Spatially Localized Immunotherapy: A Perfect Combination With Radiation Therapy?

(2021) Qinhong Wang et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going?

(2021) Francesca Varrone et al.   Cancers

Enhancing the Bystander and Abscopal Effects to Improve Radiotherapy Outcomes

(2020) Virgínea de Araújo Farias et al.   Frontiers in Oncology

Insulin-like growth factor II mRNA-binding protein 3 promotes cell proliferation, migration and invasion in human glioblastoma

(2019) Chao Wu et al.   OncoTargets and Therapy

Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer

(2018) Silvia C. Formenti et al.   CLINICAL CANCER RESEARCH

Exosomes derived from mesenchymal stem cells enhance radiotherapy-induced cell death in tumor and metastatic tumor foci

(2018) Virgínea de Araujo Farias et al.   Molecular Cancer

Radiotherapy induces responses of lung cancer to CTLA-4 blockade

(2018) Silvia C. Formenti et al.   NATURE MEDICINE

IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues

(2017) Christoph Burdelski et al.   ONCOLOGY REPORTS

Prognostic value of high IMP3 expression in solid tumors: a meta-analysis

(2017) Luyao Chen et al.   OncoTargets and Therapy

Discovery of potential biomarkers in human melanoma cells with different metastatic potential by metabolic and lipidomic profiling

(2017) Hye-Youn Kim et al.   Scientific Reports

Radiotherapy combination opportunities leveraging immunity for the next oncology practice

(2016) Fernanda G. Herrera et al.   CA-A CANCER JOURNAL FOR CLINICIANS

IMP-3 protects the mRNAs of cyclins D1 and D3 from GW182/AGO2-dependent translational repression

(2016) Evgeny Deforzh et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

IMP-3 Promotes Migration and Invasion of Melanoma Cells by Modulating the Expression of HMGA2 and Predicts Poor Prognosis in Melanoma

(2015) Yi-Shuan Sheen et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial

(2015) Encouse B Golden et al.   LANCET ONCOLOGY

Expanding global access to radiotherapy

(2015) Rifat Atun et al.   LANCET ONCOLOGY

Radiotherapy and Immunogenic Cell Death

(2015) Encouse B. Golden et al.   SEMINARS IN RADIATION ONCOLOGY

Enhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma Progression

(2015) Xuelian Pei et al.   PLoS One

To grab the stroma by the horns: From biology to cancer therapy with mesenchymal stem cells

(2015) Ilia A. Droujinine et al.   Oncotarget

Oncofetal Protein IMP3, a New Cancer Biomarker

(2014) Yuna Gong et al.   ADVANCES IN ANATOMIC PATHOLOGY

IMP3, a Promising Prognostic Marker in Clear Cell Renal Cell Carcinoma

(2014) Ji Young Park et al.   Korean Journal of Pathology

Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift

(2013) Silvia C. Formenti et al.   JNCI-Journal of the National Cancer Institute

Targeting melanoma by small molecules: challenges ahead

(2013) Rizwan Haq et al.   Pigment Cell & Melanoma Research

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

The importance of bystander effects in radiation therapy in melanoma skin-cancer cells and umbilical-cord stromal stem cells

(2011) Jaime Gómez-Millán et al.   RADIOTHERAPY AND ONCOLOGY

Human umbilical cord stromal stem cell express CD10 and exert contractile properties

(2010) V.A. Farias et al.   PLACENTA

Applications of Genomics in Melanoma Oncogene Discovery

(2009) Michael F. Berger et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

IMP-3 expression in melanocytic lesions

(2009) Limin Yu et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Understanding Melanoma Signaling Networks as the Basis for Molecular Targeted Therapy

(2009) Keiran S.M. Smalley   JOURNAL OF INVESTIGATIVE DERMATOLOGY

IMP-3 is a novel progression marker in malignant melanoma

(2008) Jennifer G Pryor et al.   MODERN PATHOLOGY